References
- Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
- Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. D. (2020). Features, evaluation and treatment Coronavirus (COVID-19). StatPearls.
- Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
- Desmond Molecular Dynamics System, D. E. Shaw Research. (2020). Maestro-Desmond interoperability tools. New York, NY: Schrödinger.
- ECT Register. (2020, April 10). https://www.clinicaltrialsregister.eu/ctr-search/search?query=covid-19.
- Fischer, A., Sellner, M., Neranjan, S., Lill, M. A., & Smieško, M. (2020). Inhibitors for novel coronavirus protease identified by virtual screening of 687 million compounds. ChemRxiv. Preprint. https://doi.org/10.26434/chemrxiv.11923239.v1
- Gahtori, J., Pant, S., & Srivastava, H. K. (2019). Modeling antimalarial and antihuman African trypanosomiasis compounds: A ligand- and structure-based approaches. Molecular Diversity. In Press. https://doi.org/10.1007/s11030-019-10015-y
- Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., & Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40(D1), D1100–1107. (Database issue): https://doi.org/10.1093/nar/gkr777
- Gordaliza, M., Castro, M. A., Garcia-Gravalos, M. D., Ruiz, P., Miguel del Corral, J. M., & San Feliciano, A. (1994). Antineoplastic and antiviral activities of podophyllotoxin related lignans. Archiv Der Pharmazie, (Weinheim), 327(3), 175–179. https://doi.org/10.1002/ardp.19943270309
- Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Hüttenhain, R., Kaake, R. M., Richards, A. L., Tutuncuoglu, B., Foussard, H., Batra, J., Haas, K., Modak, M., Kim, M., Haas, P., … Krogan, N. J. (2020). A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug repurposing. bioRxiv 2020.03.22.002386. https://doi.org/10.1101/2020.03.22.002386
- Harrison, C. (2020). Coronavirus puts drug repurposing on the fast track. Nature Biotechnology, 38(4), 379–381. https://doi.org/10.1038/d41587-020-00003-1
- Kupferschmidt, K., & Cohen, J. (2020). Will novel virus go pandemic or be contained? Science, 367(6478), 610–611. https://doi.org/10.1126/science.367.6478.610
- Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
- Lin, Z. H., Long, H. X., Bo, Z., Wang, Y. Q., & Wu, Y. Z. (2008). New descriptors of amino acids and their application to peptide QSAR study. Peptides, 29(10), 1798–1805. https://doi.org/10.1016/j.peptides.2008.06.004
- Lionta, E., Spyrou, G., Vassilatis, D. K., & Cournia, Z. (2014). Structure-based virtual screening for drug discovery: Principles, applications and recent advances. Current Topics in Medicinal Chemistry, 14(16), 1923–1938. https://doi.org/10.2174/1568026614666140929124445
- Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., & Albaiu, D. (2020). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Central Science, 6(3), 315–331. https://doi.org/10.1021/acscentsci.0c00272
- Mesecar, A. D. (2020). A taxonomically-driven approach to development of potent, broad-spectrum inhibitors of coronavirus main protease including SARS-CoV-2 (COVID-19). https://doi.org/10.2210/pdb6W63/pdb
- Murty, U. S., Srinivasa Rao, M., & Misra, S. (2008). Prioritization of malaria endemic zones using self-organizing maps in the Manipur state of India. Informatics for Health and Social Care, 33(3), 170–178. https://doi.org/10.1080/17538150802457687
- Omrani, A. S., Al-Tawfiq, J. A., & Memish, Z. A. (2015). Middle East respiratory syndrome coronavirus (MERS-CoV): Animal to human interaction. Pathogens and Global Health, 109(8), 354–362. https://doi.org/10.1080/20477724.2015.1122852
- Rein, D., Ternes, P., Demin, R., Gierke, J., Helgason, T., & Schon, C. (2019). Artificial intelligence identified peptides modulate inflammation in healthy adults. Food & Function, 10(9), 6030–6060. https://doi.org/10.1039/C9FO01398A
- Romano, J. D., & Tatonetti, N. P. (2019). Informatics and computational methods in natural product drug discovery: A review and perspectives. Frontiers in Genetics, 10, 368. https://doi.org/10.3389/fgene.2019.00368
- Sahu, K., Noskov, S., Tuszynski, J., Houghton, M., & Tyrrell, D. L. (2020). Computational screening of molecules approved in phase-i clinical trials to identify 3CL protease inhibitors to treat COVID-19. Preprint 2020. https://doi.org/10.20944/preprints202004.0015.v2
- Schrodinger. (2018). Maestro small-molecular drug discovery suite 2018-4. https://www.schrodinger.com/
- Schrödinger. (2020). Schrödinger Release 2020-1: BioLuminate. New York, NY. https://www.schrodinger.com/
- Srivastava, H. K., & Sastry, G. N. (2012). Molecular dynamics investigation on a series of HIV protease inhibitors: Assessing the performance of MM-PBSA and MM-GBSA approaches. Journal of Chemical Information and Modeling, 52(11), 3088–3098. https://doi.org/10.1021/ci300385h
- Srivastava, H. K., & Sastry, G. N. (2013). Efficient estimation of MMGBSA-based BEs for DNA and aromatic furan amidino derivatives. Journal of Biomolecular Structure and Dynamics, 31(5), 522–537. https://doi.org/10.1080/07391102.2012.703071
- Sterling, T., & Irwin, J. J. (2015). ZINC 15–Ligand Discovery for Everyone. Journal of Chemical Information and Modeling, 55(11), 2324–2337. https://doi.org/10.1021/acs.jcim.5b00559
- Vankadari, N., & Wilce, J. A. (2020). Emerging WuHan (COVID-19) coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerging Microbes & Infections, 9(1), 601–604. https://doi.org/10.1080/22221751.2020.1739565
- Wang, J. (2020). Fast identification of possible drug treatment of Coronavirus disease—19 (COVID-19) through computational drug repurposing study. ChemRxiv. https://doi.org/10.26434/chemrxiv.11875446.v1
- Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., & Zhu, W. (2020). Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020.01.27.921627. https://doi.org/10.1101/2020.01.27.921627
- Wang, L., Wang, Y., Ye, D., & Liu, D. (inpress, 2020). Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2020.105948.
- Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research, 36(suppl_1), D901–906. (Database issue): https://doi.org/10.1093/nar/gkm958
- Worldometer. (2020, April 10). https://www.worldometers.info/coronavirus/.
- Yan, A., Nie, X., Wang, K., & Wang, M. (2013). Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM). European Journal of Medicinal Chemistry, 61, 73–83. https://doi.org/10.1016/j.ejmech.2012.06.037
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science, 368(6489), 409-412. https://doi.org/10.1126/science.abb3405
- Zhavoronkov, A., Aladinskiy, V., Zhebrak, A., Zagribelnyy, B., Terentiev, V., Bezrukov, D.S., Polykovskiy, D., Shayakhmetov, R., Filimonov, A., Orekhov, P., … Yan, Y. (2020). Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. ChemRxiv. https://doi.org/10.26434/chemrxiv.11829102.v2
- Ziebuhr, J., Snijder, E. J., & Gorbalenya, A. E. (2000). Virus-encoded proteinases and proteolytic processing in the Nidovirales. Journal of General Virology, 81(4), 853–879. https://doi.org/10.1099/0022-1317-81-4-853